JP2012516319A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012516319A5 JP2012516319A5 JP2011546988A JP2011546988A JP2012516319A5 JP 2012516319 A5 JP2012516319 A5 JP 2012516319A5 JP 2011546988 A JP2011546988 A JP 2011546988A JP 2011546988 A JP2011546988 A JP 2011546988A JP 2012516319 A5 JP2012516319 A5 JP 2012516319A5
- Authority
- JP
- Japan
- Prior art keywords
- lactoferrin
- collecting
- angiogenin
- endotoxin
- lps
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 15
- 108010063045 Lactoferrin Proteins 0.000 claims 14
- 102100032241 Lactotransferrin Human genes 0.000 claims 14
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims 14
- 229940078795 lactoferrin Drugs 0.000 claims 14
- 235000021242 lactoferrin Nutrition 0.000 claims 14
- 239000002158 endotoxin Substances 0.000 claims 10
- 239000000243 solution Substances 0.000 claims 8
- 102100022987 Angiogenin Human genes 0.000 claims 5
- 108010072788 angiogenin Proteins 0.000 claims 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 4
- 241000894006 Bacteria Species 0.000 claims 3
- 206010052428 Wound Diseases 0.000 claims 3
- 208000027418 Wounds and injury Diseases 0.000 claims 3
- 239000002994 raw material Substances 0.000 claims 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 2
- 108010023244 Lactoperoxidase Proteins 0.000 claims 2
- 102000045576 Lactoperoxidases Human genes 0.000 claims 2
- 102000035195 Peptidases Human genes 0.000 claims 2
- 108091005804 Peptidases Proteins 0.000 claims 2
- 239000004365 Protease Substances 0.000 claims 2
- 239000003729 cation exchange resin Substances 0.000 claims 2
- 210000004027 cell Anatomy 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 230000002708 enhancing effect Effects 0.000 claims 2
- 229940057428 lactoperoxidase Drugs 0.000 claims 2
- 235000013336 milk Nutrition 0.000 claims 2
- 239000008267 milk Substances 0.000 claims 2
- 210000004080 milk Anatomy 0.000 claims 2
- 235000018102 proteins Nutrition 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 201000003883 Cystic fibrosis Diseases 0.000 claims 1
- 102000004127 Cytokines Human genes 0.000 claims 1
- 108090000695 Cytokines Proteins 0.000 claims 1
- 208000005577 Gastroenteritis Diseases 0.000 claims 1
- 206010024971 Lower respiratory tract infections Diseases 0.000 claims 1
- 206010057190 Respiratory tract infections Diseases 0.000 claims 1
- 210000001744 T-lymphocyte Anatomy 0.000 claims 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 claims 1
- 239000008351 acetate buffer Substances 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 210000003719 b-lymphocyte Anatomy 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 239000007853 buffer solution Substances 0.000 claims 1
- 239000000356 contaminant Substances 0.000 claims 1
- 231100000433 cytotoxic Toxicity 0.000 claims 1
- 230000001472 cytotoxic effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 238000010828 elution Methods 0.000 claims 1
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 1
- 230000002440 hepatic effect Effects 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 210000004347 intestinal mucosa Anatomy 0.000 claims 1
- 229910052742 iron Inorganic materials 0.000 claims 1
- 208000032839 leukemia Diseases 0.000 claims 1
- 210000002540 macrophage Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000035800 maturation Effects 0.000 claims 1
- 210000004379 membrane Anatomy 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 210000001616 monocyte Anatomy 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 238000011084 recovery Methods 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 208000003265 stomatitis Diseases 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 claims 1
- 230000017423 tissue regeneration Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20208809P | 2009-01-28 | 2009-01-28 | |
| US61/202,088 | 2009-01-28 | ||
| PCT/IB2010/000149 WO2010112988A1 (en) | 2009-01-28 | 2010-01-28 | Method for production of lactoferrin |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012516319A JP2012516319A (ja) | 2012-07-19 |
| JP2012516319A5 true JP2012516319A5 (enExample) | 2013-03-14 |
| JP5718254B2 JP5718254B2 (ja) | 2015-05-13 |
Family
ID=41818728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011546988A Expired - Fee Related JP5718254B2 (ja) | 2009-01-28 | 2010-01-28 | ラクトフェリンの製造方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9115211B2 (enExample) |
| EP (1) | EP2391225B1 (enExample) |
| JP (1) | JP5718254B2 (enExample) |
| CN (1) | CN102348387B (enExample) |
| AU (1) | AU2010231075B2 (enExample) |
| CA (1) | CA2750701C (enExample) |
| DK (1) | DK2391225T3 (enExample) |
| ES (1) | ES2805279T3 (enExample) |
| NZ (1) | NZ594212A (enExample) |
| PL (1) | PL2391225T3 (enExample) |
| RU (1) | RU2579661C2 (enExample) |
| WO (1) | WO2010112988A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013204858B2 (en) * | 2012-10-08 | 2015-06-25 | Saputo Dairy Australia Pty Limited | Improved process for purifying milk proteins and products thereof |
| AU2013204850B2 (en) * | 2012-10-08 | 2015-06-25 | Murray Goulburn Co-Operative Co. Limited | Improved process for purifying milk proteins and products thereof |
| RO130063A8 (ro) | 2014-08-28 | 2017-06-30 | Romvac Company S.A. | Producerea şi utilizarea ovotransferinei moderne () |
| JPWO2016136904A1 (ja) * | 2015-02-26 | 2017-12-07 | 味の素株式会社 | チーズの製造方法及びチーズ改質用の製剤 |
| FR3046603B1 (fr) | 2016-01-11 | 2017-12-29 | Michelin & Cie | Procede de modification d'un caoutchouc naturel et caoutchouc naturel modifie |
| CN117942405A (zh) | 2016-02-25 | 2024-04-30 | 应用生物实验室公司 | 保护空气传播的病原体和刺激物的组合物和方法 |
| US12447166B2 (en) * | 2016-02-25 | 2025-10-21 | Applied Biological Laboratories, Inc. | Compositions and methods for protecting against airborne pathogens and irritants |
| CN112996806A (zh) * | 2018-11-06 | 2021-06-18 | 安赫尔工程建模有限责任公司 | 从奶、初乳和酸乳清或甜乳清中制备高纯度乳铁蛋白和乳过氧化物酶的方法 |
| JPWO2021153508A1 (enExample) | 2020-01-30 | 2021-08-05 | ||
| AU2020203454B1 (en) * | 2020-05-26 | 2021-07-22 | HPS Tech Pty Ltd | Processing protein |
| FR3115037B1 (fr) | 2020-10-12 | 2025-02-21 | Cie Laitiere Europeenne | Procédé de purification de fraction de protéines cationiques et fraction ainsi obtenue |
| UY39909A (es) * | 2021-08-23 | 2023-03-31 | Lactea Therapeutics Llc | Composiciones de lactoferrina y métodos de uso |
| IL311036A (en) * | 2021-08-23 | 2024-04-01 | Lactea Therapeutics Llc | Lactoferrin compositions and methods of use |
| US20250136666A1 (en) * | 2021-11-16 | 2025-05-01 | Noumi Limited | A method for producing a lactoferrin powder and uses thereof |
| DE202023102334U1 (de) | 2023-04-28 | 2023-06-07 | Mercurius Production Gmbh | Lactoferrin und Vorrichtung zu dessen Herstellung |
| PL444766A1 (pl) * | 2023-05-07 | 2024-11-12 | Polmlek Spółka Z Ograniczoną Odpowiedzialnością | Sposób uzyskiwania laktoferyny w proszku z surowego mleka |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE61701B1 (en) * | 1986-07-17 | 1994-11-30 | Morinaga Milk Industry Co Ltd | Process for producing bovine lactoferrin in high purity |
| US5571697A (en) * | 1989-05-05 | 1996-11-05 | Baylor College Of Medicine Texas Medical Center | Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in Aspergillus |
| JP2686831B2 (ja) * | 1989-09-22 | 1997-12-08 | 雪印乳業株式会社 | 鉄結合性蛋白質を分離、精製し、採取する方法 |
| US6096870A (en) * | 1994-01-05 | 2000-08-01 | Sepragen Corporation | Sequential separation of whey |
| JPH09509165A (ja) * | 1994-02-16 | 1997-09-16 | ファーミング ベスローテン フェンノートシャップ | ミルクからのラクトフェリンの分離 |
| JPH08217693A (ja) * | 1995-02-17 | 1996-08-27 | Yoshihisa Naito | 新規医薬組成物 |
| JP2974604B2 (ja) * | 1996-01-23 | 1999-11-10 | 雪印乳業株式会社 | 塩基性タンパク質組成物、塩基性ペプチド組成物及びその利用 |
| JPH1059864A (ja) * | 1996-08-15 | 1998-03-03 | Morinaga Milk Ind Co Ltd | 経口がん転移抑制剤 |
| JP2002326950A (ja) * | 2001-05-02 | 2002-11-15 | Meiji Milk Prod Co Ltd | 炎症性サイトカイン産生抑制剤 |
| US20030096736A1 (en) * | 2001-05-09 | 2003-05-22 | Kruzel Marian L. | Lactoferrin for age related disorders in humans |
| WO2003094952A1 (en) * | 2002-05-10 | 2003-11-20 | Agennix Incorporated | Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| AU2003233583A1 (en) * | 2002-05-24 | 2003-12-12 | Agennix Incorporated | Oral lactoferrin in the treatment of respiratory disorders |
| CA2542291A1 (en) * | 2004-02-03 | 2005-08-18 | Kurume University | Method for separating/refining cationic protein |
| CA2608281A1 (en) | 2005-05-13 | 2006-11-16 | Crea Biopharma Inc. | New purification method of lactoferrin |
| JP5087297B2 (ja) * | 2007-03-05 | 2012-12-05 | 森永乳業株式会社 | インターロイキン−11産生促進剤 |
| CN101117351B (zh) * | 2007-04-30 | 2010-08-18 | 北京济普霖生物技术有限公司 | 一种从转基因牛乳中纯化重组人乳铁蛋白的方法 |
| NZ583234A (en) | 2007-07-10 | 2012-06-29 | Glanbia Nutritionals | Method for removing endotoxin from proteins |
-
2010
- 2010-01-28 RU RU2011135536/10A patent/RU2579661C2/ru active
- 2010-01-28 CN CN201080010953.6A patent/CN102348387B/zh not_active Expired - Fee Related
- 2010-01-28 ES ES10703352T patent/ES2805279T3/es active Active
- 2010-01-28 PL PL10703352T patent/PL2391225T3/pl unknown
- 2010-01-28 DK DK10703352.4T patent/DK2391225T3/da active
- 2010-01-28 CA CA2750701A patent/CA2750701C/en not_active Expired - Fee Related
- 2010-01-28 AU AU2010231075A patent/AU2010231075B2/en not_active Ceased
- 2010-01-28 WO PCT/IB2010/000149 patent/WO2010112988A1/en not_active Ceased
- 2010-01-28 JP JP2011546988A patent/JP5718254B2/ja not_active Expired - Fee Related
- 2010-01-28 US US13/146,798 patent/US9115211B2/en active Active - Reinstated
- 2010-01-28 NZ NZ594212A patent/NZ594212A/xx not_active IP Right Cessation
- 2010-01-28 EP EP10703352.4A patent/EP2391225B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012516319A5 (enExample) | ||
| RU2011135536A (ru) | Способ производства лактоферрина | |
| JP7116823B2 (ja) | 新規なトリプシンアイソフォームおよびそれらの使用 | |
| CN103160482B (zh) | 一种共分离制备鸡蛋清溶菌酶与活性蛋白的方法 | |
| JP2013505011A5 (enExample) | ||
| KR20170049432A (ko) | 상처 유합, 콜라겐 생성, 혈관 신생, 면역세포 활성화를 촉진시키고 상처 감염을 저감시킬 수 있는 펩티드 및 이의 용도 | |
| CN103819577A (zh) | 一种螺旋藻多糖的制备方法 | |
| JP2015536905A5 (enExample) | ||
| CN112891295A (zh) | 一种外泌体漱口水及其制备方法和应用 | |
| JP5908496B2 (ja) | トランスジェニックイネの子実からヒト血清アルブミンを抽出する方法 | |
| CN1407108A (zh) | 表达乳铁蛋白的基因工程重组菌株及其应用 | |
| CN103060294B (zh) | 一种能够去除热原及病毒的尿激酶的制备方法 | |
| CN103789373B (zh) | 一种利用固定化酶提取肝素钠的方法 | |
| CN102191234A (zh) | 鸡蛋清溶菌酶的分离纯化方法 | |
| CN102643342A (zh) | 一种泥蚶血红蛋白Tg-HbIIA及其应用 | |
| CN102823715A (zh) | 一种全仿生消化模型法制备生物活性肽的方法 | |
| CN1328062A (zh) | 高纯度魔芋葡甘聚糖的提取工艺 | |
| CN103937736A (zh) | 鱼鳃细胞系的建立方法 | |
| CN105077215B (zh) | 以唐古特白刺多糖作为天然抑菌剂的冬虫夏草保鲜产品 | |
| CN104031901B (zh) | 一种纯化尿激酶的方法 | |
| CN113528600A (zh) | 一种利用沙门氏菌诱导蝇蛆制备抗菌肽的方法 | |
| CN110922506A (zh) | 一种高澄清度的肝素钠 | |
| JP7454211B2 (ja) | バクテリオファージ由来エンドライシン | |
| CN103880917A (zh) | 鸡肠道抗菌肽的提取方法 | |
| JPS6041615A (ja) | コロニ−形成刺激因子の製造方法 |